Related Experiment Videos
Tyrosine kinase and control of cell proliferation
P M Comoglio1, M F Di Renzo, G Gaudino
1Department of Biomedical Sciences and Oncology, University of Torino Medical School, Italy.
Abstract:
The usefulness of phosphotyrosine antibodies for the detection of physiologically regulated or deregulated tyrosine kinases is discussed in this report. This rather rare enzymatic activity is shared by receptors for some polypeptide growth factors and by the products of Class 1 oncogenes. The antibodies are able to detect proteins phosphorylated on tyrosine in fibroblasts stimulated with growth factors such as EGF and PDGF. The major phosphorylated protein species are the receptors themselves, which undergo phosphorylation only after the addition of the exogenous factor and only transiently. Phosphotyrosine antibodies were able to detect the products of the retroviral Class 1 oncogenes, which are endowed with deregulated tyrosine kinase activity. In fact, in these cases a constitutive phosphorylation of the relevant proteins was observed, which occurred continuously and independently of the presence or lack of exogenous ligands. A tyrosine kinase constitutively activated in human gastric carcinoma cells was detected by P-Tyr antibodies. This molecule has been characterized at the molecular level, and the mechanisms responsible for its enzymatic activation have been investigated. The question of whether the tyrosine kinase identified is responsible for the induction and the maintenance of the transformed phenotype in gastric carcinomas remains to be answered. It is reasonable to suggest that this might be the case by analogy with other situations such as Class 1 oncogenes activated by transduction by retroviruses, abnormal expression of EGF receptors, or deregulated activity of c-abl-encoded proteins in chronic myelogenous leukemia and acute lymphoblastic leukemia. Thus, the search for deregulated kinases by means of phosphotyrosine antibodies seems to be useful for identifying new activated oncogenes in clinical oncology.
Insights
Phosphotyrosine antibodies detect tyrosine kinases, crucial in cell growth and cancer. These antibodies identify both normal, regulated kinases and abnormal, deregulated kinases found in cancers like gastric carcinoma, aiding oncogene discovery.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Tyrosine kinases are enzymes with rare enzymatic activity, implicated in cell growth regulation and cancer.
- Receptors for polypeptide growth factors and products of Class 1 oncogenes possess tyrosine kinase activity.
- Dysregulated tyrosine kinase activity is a hallmark of various cancers.
Purpose of the Study:
- To evaluate the utility of phosphotyrosine antibodies in detecting physiologically regulated and deregulated tyrosine kinases.
- To investigate the role of tyrosine kinases in normal cellular processes and in oncogenesis.
- To explore the potential of phosphotyrosine antibodies for identifying novel oncogenes in clinical oncology.
Main Methods:
- Utilized phosphotyrosine antibodies to detect phosphorylated proteins in stimulated fibroblasts and cancer cells.
- Analyzed protein phosphorylation patterns in response to growth factors (EGF, PDGF) and in the presence of oncogenes.
- Characterized a constitutively activated tyrosine kinase in human gastric carcinoma cells.
Main Results:
- Phosphotyrosine antibodies successfully detected transient phosphorylation of growth factor receptors (e.g., EGF, PDGF) upon stimulation.
- These antibodies identified constitutively phosphorylated proteins associated with deregulated tyrosine kinase activity from Class 1 oncogenes.
- A constitutively activated tyrosine kinase was detected and molecularly characterized in gastric carcinoma cells.
Conclusions:
- Phosphotyrosine antibodies are effective tools for detecting both normal and aberrant tyrosine kinase activity.
- The identification of deregulated kinases using these antibodies holds promise for discovering new activated oncogenes in cancer.
- Further research is needed to confirm the role of the identified gastric carcinoma tyrosine kinase in tumor development.